Search

  • LAAO Summit 2023

    ON DEMAND - LAAO SUMMIT 2023 12th Global Left Atrial Appendage Occlusion Summit LAAO SUMMIT 2023 - Welcome Left Atrial Appendage Occlusion therapy has become an established and increasingly…
  • Test page

    TEST PAGE xxx SOLUTIONS TEST Check if your logged user sees the right products. CONTENT TEST Check if your logged user sees the right videos.
  • Clinic Portal Search

    © Abbott 2023. All rights reserved. 9-EH-5-14585-01 10-2023
  • Treatment

    HEART FAILURE MANAGEMENT OPTIONS Management options for heart failure may include a combination of lifestyle changes, medications, implantable devices such as a pacemaker or defibrillator providing…
  • Treat

    While there is no true cure for heart failure, today’s therapies and monitoring options help more people than ever to manage their heart failure, live longer and improve their quality of life. …
  • Connext TV

    © Abbott 2023. All rights reserved. 9-EH-5-14558-01 09-2023
  • Connext

    ConnextTV Visit our dedicated channel  for the latest videos, animations  and interviews.   Find out more Therapies Valvular Diseases …
  • Patients who benefit

    Real-world evidence shows a significant relationship between degree of residual MR and survival after transcatheter mitral repair. Tendyne™ is an option for select MR patients who may benefit from…
  • Patients who benefit

    49% of patients with symptomatic severe MR were not operated due to age, co-morbidities, or impaired LV.5 If left untreated, MR initiates a cascade of events leading to death, with 1-year…
  • Diagnosis

    MR is a progressive disease, and patients may remain asymptomatic even when the condition has become severe, as compensatory mechanisms develop.11 In some cases, the following symptoms may be…

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.